Follow the GRI BIO, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.6m. The latest transaction was disclosed on 24 April 2023 (Attribution). Among the most active insiders: Chaturvedi Vipin. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
GRI BIO, Inc. is a company listed on the XNAS market, specializing in the development of innovative biological solutions. It focuses on research and commercialization of products to enhance sustainability across various sectors.